Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland

被引:25
作者
Dzierzanowska-Fangrat, K
Rozynek, E
Józwiak, P
Celinska-Cedro, D
Madalinski, K
Dzierzanowska, D
机构
[1] Childrens Mem Hlth Inst, Dept Clin Immunol, PL-04736 Warsaw, Poland
[2] Childrens Mem Hlth Inst, Dept Clin Microbiol, PL-04736 Warsaw, Poland
[3] Childrens Mem Hlth Inst, Dept Gastroenterol & Nutr, PL-04736 Warsaw, Poland
关键词
Helicobacter pylori; clarithromycin; resistance; children;
D O I
10.1016/S0924-8579(01)00421-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Helicobacter pylori resistance to clarithromycin is an important factor in the failure of eradication therapy. The resistance results from point mutations in the 23S rRNA gene of H. pylori. The prevalence of primary resistance of H. pylori to clarithromycin in children and mutations associated with resistance were studied and it was found that 23.5% (23/98) of H. pylori strains isolated in our hospital during 1998-2000 were resistant to clarithromycin. The primary resistance was mainly caused by an A2143G mutation, but the isolates with an A2142G mutation had higher MICs for clarithromycin compared with those with an A2143G mutation: median MIC 256 versus 16 mg/l. Comparison of our data with previous results showed that the prevalence of H. pylori resistance to clarithromycin in children has increased in Poland over the last three years, however the difference was not significant (23.5 vs. 17%, P = 0.22). (C) 2001 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:387 / 390
页数:4
相关论文
共 13 条
  • [1] GABRYELEWICZ A, 2000, GASTROENTEROLOGIA, V1, P194
  • [2] Glupczynski Y, 2000, GUT, V47, pA6
  • [3] High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children
    Kalach, N
    Bergeret, M
    Benhamou, PH
    Dupont, C
    Raymond, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) : 394 - 397
  • [4] Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure
    Matsuoka, M
    Yoshida, Y
    Hayakawa, K
    Fukuchi, S
    Sugano, K
    [J]. GUT, 1999, 45 (04) : 503 - 507
  • [5] Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial:: the MACH 2 study
    Mégraud, F
    Lehn, N
    Lind, T
    Bayerdörffer, E
    O'Morain, C
    Spiller, R
    Unge, P
    Van Zanten, SV
    Wrangstadh, M
    Burman, CF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2747 - 2752
  • [6] Macrolide resistance in Helicobacter pylori: Rapid detection of point mutations and assays of macrolide binding to ribosomes
    Occhialini, A
    Urdaci, M
    DoucetPopulaire, F
    Bebear, CM
    Lamouliatte, H
    Megraud, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) : 2724 - 2728
  • [7] Primary resistance to metronidazole and other antibiotics of Helicobacter pylori isolated from children in Poland
    Rozynek, E
    Dzierzanowska, D
    Celinska-Cedro, D
    Jeljaszewicz, J
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (12) : 943 - 944
  • [8] SIPPONEN P, 1992, SCAND J GASTR S196, V28, P3
  • [9] Stone G G, 1996, Helicobacter, V1, P227, DOI 10.1111/j.1523-5378.1996.tb00043.x
  • [10] Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance
    Versalovic, J
    Osato, MS
    Spakovsky, K
    Dore, MP
    Reddy, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (02) : 283 - 286